Overcoming 5 Common Barriers to Harmonised Real World Data
Dr. Andrew Roche discusses overcoming the challenges and considerations associated with NASH Clinical Trials and examination of potential strategies to address during trial design or study execution.
Our experts explore how manufacturers can successfully implement the FDA's guidance on Payer Communications and integrate these new communication channels with payers
Review insights on ALS studies and recruitment challenges involving newly diagnosed rare disease participants.
This webinar explores: the evolution of health technology assessment in the US and possibilities for the future; opinions of manufacturers and US payer stakeholders on the role of ICER in the US healthcare system; ICER methodologies and approaches